Dobutrex

DRUG3 trials

Sponsors

Region Midtjylland, Rigshospitalet, Steen Hvitfeldt Poulsen

Conditions

ATTR Amyloidosis Wild TypeAcute Myocardial Infarction with increased risk of Cardiogenic ShockWild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

Phase 1

Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

RecruitingNCT06318260

Steen Hvitfeldt PoulsenATTR Amyloidosis Wild Type

Start: 2024-04-08End: 2026-03-31Target: 35Updated: 2024-04-17

Phase 2

Haemodynamic Effects of Dobutamine in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

RecruitingCTIS2023-508298-10-00

Region MidtjyllandWild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

Start: 2024-04-01Target: 35Updated: 2023-12-08

Phase 4

LOW-DOSE DOBUTAMINE INFUSION AND SINGLE-DOSE TOCILIZUMAB IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH RISK OF CARDIOGENIC SHOCK DEVELOPMENT (DOBERMANN) - A 2X2 MULTIFACTORIAL, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

CompletedCTIS2024-515999-13-00

RigshospitaletAcute Myocardial Infarction with increased risk of Cardiogenic Shock

Start: 2022-03-13End: 2025-09-30Target: 100Updated: 2025-03-25